Serum Metabolomic Profiling Reveals Disrupted Amino Acid and Fatty Acid Metabolism in Older Adults with Sarcopenia
Gerontology · 2026-10-29
DOI: 10.1159/ger/acxag013 ↗Abstract
Introduction: Sarcopenia, an age-related syndrome characterized by progressive loss of muscle mass, decreased muscle strength, and/or reduced physical performance, is associated with disruptions in amino acid and lipid metabolism. This study aimed to investigate serum metabolic alterations associated with sarcopenia in older adults. Methods: In this cross-sectional study, 50 patients with sarcopenia (diagnosed per 2014 AWGS criteria) were matched 1:1 by age and sex with non-sarcopenic controls from a pool of 2,965 individuals. Assessments included skeletal muscle mass, grip strength, and gait speed. Serum metabolomic profiling was conducted using liquid chromatography-mass spectrometry (LC-MS). The screening of differential metabolites: variable importance in the projection (VIP) > 1 derived from the OPLS-DA model, and adjusted p-value based on false discovery rate (FDR) < 0.05 calculated by two-sample t-test. Results: Among 100 participants aged 60–87 years, individuals with sarcopenia showed significantly lower BMI, grip strength, albumin, and ASMI than controls (all p < 0.05), whereas lipid levels were comparable. PCA suggested weak group separation, whereas PLS-DA achieved clearer discrimination by sex and sarcopenia status. Differential metabolites identified in the sarcopenia group included arginine, leucine and histidinyl-histidine, the latter of which exhibited decreased abundance. Concomitant alterations in the levels of lipid metabolites collectively suggest disrupted amino acid and lipid metabolism. Conclusion: Patterns of dysregulated amino acid and fatty acid metabolism were observed in older adults with sarcopenia. Such metabolic disturbances might serve as candidate biomarkers to inform early detection and nutritional intervention strategies.
EUVIMED